Disseminated Fusarium Infection Originating from Paronychia in a Neutropenic Patient: a Case Report and Review of the Literature

Overview

Journal Cutis

Specialty Dermatology

Date 2010 May 22

PMID 20486458

Citations 10

Authors

Greg P Bourgeois

Jennifer A Cafardi

Klaus Sellheyer

Aleodor A Andea

Affiliations

Soon will be listed here.

Abstract

Fusarium is a saprophytic organism that is widely found distributed in soil, subterranean and aerial plants, plant debris, and other organic substrates. It can cause local tissue infections in immunocompetent patients, such as onychomycosis, bone and joint infections, or sinusitis. The incidence of disseminated disease has notably increased since the initial cases of disseminated Fusarium were described, particularly affecting immunocompromised patients with hematologic malignancies. We report a 39-year-old man hospitalized with newly diagnosed acute myelocytic leukemia who developed disseminated Fusarium infection originating from toenail paronychia in the setting of neutropenia. Pathologic diagnosis of Fusarium is difficult because the septate hyphae of Fusarium are difficult to distinguish from Aspergillus, which has a more favorable outcome. Cultures of potential sources of infection as well as tissue cultures are essential in identifying the organism and initiating early aggressive therapy.

Citing Articles

Clinical spectrum of fusariosis from a tertiary care center in India- a retrospective study.

Sudhaharan S, Pamidimukkala U, Singh K, Chavali P Iran J Microbiol. 2024; 16(1):145-150.

PMID: 38682054 PMC: 11055442. DOI: 10.18502/ijm.v16i1.14884.

Non- Hyaline Molds: A Host-Based Perspective of Emerging Pathogenic Fungi Causing Sinopulmonary Diseases.

Jacobs S, Walsh T J Fungi (Basel). 2023; 9(2).

PMID: 36836326 PMC: 9964096. DOI: 10.3390/jof9020212.

A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.

Capriotti K, Anadkat M, Choi J, Kaffenberger B, McLellan B, Barone S Invest New Drugs. 2019; 37(6):1247-1256.

PMID: 31240513 PMC: 7484976. DOI: 10.1007/s10637-019-00825-0.

Reduced Multidrug Susceptibility Profile Is a Common Feature of Opportunistic Fusarium Species: Fusarium Multi-Drug Resistant Pattern.

Taj-Aldeen S J Fungi (Basel). 2018; 3(2).

PMID: 29371536 PMC: 5715927. DOI: 10.3390/jof3020018.

Fusarium spp. is able to grow and invade healthy human nails as a single source of nutrients.

Galletti J, Negri M, Grassi F, Kioshima-Cotica E, Svidzinski T Eur J Clin Microbiol Infect Dis. 2015; 34(9):1767-72.

PMID: 26007318 DOI: 10.1007/s10096-015-2410-1.

References

Rothe A, Seibold M, Hoppe T, Seifert H, Engert A, Caspar C . Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann Hematol. 2003; 83(6):394-7. DOI: 10.1007/s00277-003-0795-x. View

Nucci M, Anaissie E . Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002; 35(8):909-20. DOI: 10.1086/342328. View

Nucci M, Anaissie E, Queiroz-Telles F, Martins C, Trabasso P, Solza C . Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003; 98(2):315-9. DOI: 10.1002/cncr.11510. View

Dignani M, Anaissie E . Human fusariosis. Clin Microbiol Infect. 2004; 10 Suppl 1:67-75. DOI: 10.1111/j.1470-9465.2004.00845.x. View

Nucci M, Anaissie E . Emerging fungi. Infect Dis Clin North Am. 2006; 20(3):563-79. DOI: 10.1016/j.idc.2006.06.002. View

Nucci M, Anaissie E . Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007; 20(4):695-704. PMC: 2176050. DOI: 10.1128/CMR.00014-07. View

Vagace J, Sanz-Rodriguez C, Casado M, Alonso N, Garcia-Dominguez M, de la Llana F . Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report. BMC Infect Dis. 2007; 7:40. PMC: 1878481. DOI: 10.1186/1471-2334-7-40. View

Cordoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale R . In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents. 2007; 31(2):171-4. DOI: 10.1016/j.ijantimicag.2007.09.005. View

Dignani M, Anaissie E, Hester J, OBrien S, Vartivarian S, Rex J . Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia. 1997; 11(10):1621-30. DOI: 10.1038/sj.leu.2400811. View

10.

Ponton J, Ruchel R, Clemons K, Coleman D, Grillot R, Guarro J . Emerging pathogens. Med Mycol. 2001; 38 Suppl 1:225-36. DOI: 10.1080/mmy.38.s1.225.236. View

11.

Bodey G, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem R . Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002; 47(5):659-66. DOI: 10.1067/mjd.2002.123489. View

12.

Nucci M, Marr K, Queiroz-Telles F, Martins C, Trabasso P, Costa S . Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2004; 38(9):1237-42. DOI: 10.1086/383319. View

13.

Ho D, Lee J, Rosso F, Montoya J . Treating disseminated fusariosis: amphotericin B, voriconazole or both?. Mycoses. 2007; 50(3):227-31. DOI: 10.1111/j.1439-0507.2006.01346.x. View

14.

Ortoneda M, Capilla J, Pastor F, Pujol I, Guarro J . In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diagn Microbiol Infect Dis. 2004; 48(1):69-71. DOI: 10.1016/j.diagmicrobio.2003.09.003. View

15.

Nelson P, Dignani M, Anaissie E . Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev. 1994; 7(4):479-504. PMC: 358338. DOI: 10.1128/CMR.7.4.479. View

16.

Boutati E, Anaissie E . Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood. 1997; 90(3):999-1008. View

17.

Mays S, Bogle M, Bodey G . Cutaneous fungal infections in the oncology patient: recognition and management. Am J Clin Dermatol. 2006; 7(1):31-43. DOI: 10.2165/00128071-200607010-00004. View

18.

Stanzani M, Vianelli N, Bandini G, Paolini S, Arpinati M, Bonifazi F . Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect. 2006; 53(6):e243-6. DOI: 10.1016/j.jinf.2006.02.011. View

19.

Anaissie E, Kuchar R, Rex J, Francesconi A, Kasai M, Muller F . Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis. 2001; 33(11):1871-8. DOI: 10.1086/324501. View

20.

Cho C, Vats T, LOWMAN J, BRANDSBERG J, TOSH F . Fusarium solani infection during treatment for acute leukemia. J Pediatr. 1973; 83(6):1028-31. DOI: 10.1016/s0022-3476(73)80543-8. View